COP31 climate talks enter final day as fossil fuel pledges dropped
World leaders and negotiators are racing to secure a deal at the COP31 climate summit in Türkiye, as criticism mounts over a revised draft agr...
The war in the Middle East is beginning to disrupt the flow of critical medicines to Gulf countries, raising concerns about the supply of cancer treatments and other temperature-sensitive drugs, according to pharmaceutical industry executives.
Air routes and shipping lanes across the region have been affected by the escalating conflict, forcing drugmakers and logistics companies to reroute shipments and search for alternative ways to move medicines into the Gulf.
Although there are no widespread shortages yet, industry leaders warn that supplies could become strained if the conflict continues.
The latest disruption follows U.S. and Israeli attacks on Iran two weeks ago, which were followed by Iranian strikes across the region. The escalating hostilities have led to the closure of major airports and shipping routes that are central to global cargo networks.
Airports in Dubai, Abu Dhabi and Doha - key logistics hubs linking Europe with Asia and Africa - have been shut following the strikes. These airports normally handle large volumes of pharmaceutical cargo transported by major airlines and global logistics companies.
The closures have slowed the movement of many goods, from medicines to food and oil, creating wider supply-chain challenges across the region.
Pharmaceutical companies say the disruption poses particular risks for medicines that require strict temperature control. Many cancer treatments and specialised drugs must be kept within a narrow temperature range to remain safe and effective.
Executives warn that these medicines rely on tightly managed “cold-chain” transport systems designed to keep products refrigerated throughout their journey.
Because some drugs also have short shelf lives, delays or longer routes can quickly complicate deliveries.
In response, Western pharmaceutical companies are seeking alternative entry points into the Gulf.
Some shipments are now being routed through airports in Saudi Arabia, such as Jeddah and Riyadh, before being transported overland by truck to other countries in the region. Other companies are exploring routes through Istanbul or Oman.
One pharmaceutical executive said companies had set up internal teams to prioritise shipments of patient-critical medicines, including cancer treatments.
However, they warned that some temperature-controlled cargo could still miss connections unless suitable storage and handling facilities are available along the new routes.
Medical device and pharmaceutical firms are also reviewing supply chains to manage the disruption.
One industry executive said the first step was identifying shipments already in transit or waiting to depart. Companies then had to decide which deliveries should be diverted and whether entirely new shipping plans were needed.
For now, the industry is managing the disruption, but executives caution that a prolonged conflict could place increasing pressure on the supply of essential medicines across the Gulf.
U.S. President Donald Trump, Russian President Vladimir Putin and Chinese President Xi Jinping are holding trilateral talks at the APEC summit in Shenzhen, China, with Ukraine, nuclear arms control and global security on the agenda.
U.S. President Donald Trump has joined Russian counterpart and leaders from across the Asia-Pacific region in Shenzhen for the 33rd Asia-Pacific Economic Cooperation (APEC) Summit, where trade, economic cooperation and AI are set to take centre stage.
Myanmar's security forces committed genocide against Rohingya Muslims during a brutal military crackdown in 2017 that killed thousands and involved widespread sexual violence, the United Nations' top court ruled on 19 November.
U.S. President Donald Trump, China's Xi Jinping and Russia's Vladimir Putin have issued a joint “declaration of peace” following historic talks in southern China, but stopped short of committing to nuclear arms reductions or addressing the war in Ukraine in their joint statement.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment